The Current Ratio as of December 2025 (TTM) for CERo Therapeutics Holdings, Inc. (CERO) is 0.30

According to CERo Therapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.30. This represents a change of -42.33% compared to the average of 0.52 of the last 4 quarters.

CERo Therapeutics Holdings, Inc. (CERO) Historical Current Ratio (quarterly & annually)

How has CERO Current Ratio performed in the past?

The mean historical Current Ratio of CERo Therapeutics Holdings, Inc. over the last ten years is 4.03. The current 0.30 Current Ratio has changed 648.69% with respect to the historical average. Over the past ten years (40 quarters), CERO's Current Ratio was at its highest in in the June 2021 quarter at 24.00. The Current Ratio was at its lowest in in the September 2021 quarter at 0.09.

CERo Therapeutics Holdings, Inc. (CERO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of CERo Therapeutics Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CERo Therapeutics Holdings, Inc. (CERO) Average Current Ratio

How has CERO Current Ratio performed in the past?

The current Current Ratio of CERo Therapeutics Holdings, Inc. (CERO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

CERo Therapeutics Holdings, Inc. (CERO) Current Ratio vs. Peers

How is CERO’s Current Ratio compared to its peers?

CERo Therapeutics Holdings, Inc.’s Current Ratio is less than Liminatus Pharma, Inc. Class A Common Stock (0.42), less than XORTX Therapeutics Inc. (1.78), greater than Ocean Biomedical, Inc. (0.06), less than Galmed Pharmaceuticals Ltd. (8.71), greater than NKGen Biotech, Inc. Common Stock (0), less than BioVie Inc. (15.83), less than PMGC Holdings Inc. (1.79), less than BriaCell Therapeutics Corp. Warrant (3.41), less than Moolec Science S.A. (1.48), greater than Protagenic Therapeutics, Inc. (0.29),

Build a custom stock screener for CERo Therapeutics Holdings, Inc. (CERO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CERo Therapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CERo Therapeutics Holdings, Inc. (CERO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CERo Therapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.